electroCore Announces First Quarter 2023 Financial Results
03 mai 2023 16h01 HE
|
electroCore, Inc.
Record first quarter 2023 net sales of $2.8 million, approximately 46% over first quarter 2022 Company to host a conference call and webcast today, May 3, 2023, at 4:30 PM EDT ROCKAWAY, N.J., May ...
electroCore to Participate at Annual Aegis Virtual Conference
01 mai 2023 16h01 HE
|
electroCore, Inc.
ROCKAWAY, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s...
National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders
26 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the National Institute on...
Study Presented at 75th Annual Meeting of the American Academy of Neurology Demonstrates that gammaCore (nVNS) Can Accelerate Foreign Language Learning
24 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research...
electroCore to Announce First Quarter Financial Results on Wednesday, May 3
19 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 19, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the...
electroCore Provides Select First Quarter 2023 Financial Guidance
17 avr. 2023 08h00 HE
|
electroCore, Inc.
Record revenue of approximately $2.8M expected for the three months ended March 31, 2023; 46% increase over first quarter of 2022 Revenue in first full quarter of Truvaga sales of approximately...
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
12 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue...
electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan
11 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Teijin...
electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa
06 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the receipt of a...
electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute
04 avr. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., April 04, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the...